Patient preferences for treating refractory overactive bladder in the UK

A Community-Engaged Approach to Quantifying Caregiver Preferences for the Benefits and Risks of Emerging Therapies for Duchenne Muscular Dystrophy

(2014) Holly L. Peay et al.   CLINICAL THERAPEUTICS

Women’s perspective: intra-detrusor botox versus sacral neuromodulation for overactive bladder symptoms after unsuccessful anticholinergic treatment

(2014) Pooja Balchandra et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Tolterodine for the treatment of urge urinary incontinence

(2013) Dean S Elterman et al.   EXPERT OPINION ON PHARMACOTHERAPY

Defining and Managing Overactive Bladder: Disagreement Among the Experts

(2013) Una J. Lee et al.   UROLOGY

Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB

(2012) Linda Brubaker et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction

(2011) Debra E. Irwin et al.   BJU INTERNATIONAL

The Association of Adiposity and Overactive Bladder Appears to Differ by Gender: Results From the Boston Area Community Health Survey

(2011) Carol L. Link et al.   JOURNAL OF UROLOGY

Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome

(2011) Ricarda M. Bauer et al.   UROLOGIA INTERNATIONALIS

Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study

(2010) Kathleen M Beusterien et al.   Health and Quality of Life Outcomes

Satisfaction and Patient Experience With Sacral Neuromodulation: Results of a Single Center Sample Survey

(2010) Randall K. Leong et al.   JOURNAL OF UROLOGY

Valuing citizen and patient preferences in health: recent developments in three types of best–worst scaling

(2010) Terry N Flynn   Expert Review of Pharmacoeconomics & Outcomes Research

Societal preference values for advanced melanoma health states in the United Kingdom and Australia

(2009) K M Beusterien et al.   BRITISH JOURNAL OF CANCER

An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction

(2009) Bernard T. Haylen et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy

(2009) F. Reed Johnson et al.   JOURNAL OF NEUROLOGY